文献速递糖尿病骨质疏松与钙磷/甲状旁腺

高血糖、糖尿病与脆性骨折风险:观察性与孟德尔随机化研究

Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies.
PubMed 文献 · Diabetologia · 2023-12-14

孟德尔随机化支持高血糖对臂部骨折的因果效应,糖尿病合并脆性骨折者全因死亡风险最高。

要点

  • 1型糖尿病脆性骨折风险HR 1.50(95%CI 1.19,1.88),2型糖尿病HR 1.22(95%CI 1.13,1.32)。
  • 孟德尔随机化支持高非空腹血糖与臂部骨折因果关联(RR 1.41,95%CI 1.11,1.79)。
  • 80岁时,糖尿病合并脆性骨折者累积死亡67%,高于单纯糖尿病54%和单纯骨折27%。

核心结论

  • 高血糖和糖尿病是脆性骨折的危险因素,孟德尔随机化分析支持高血糖对臂部骨折的因果效应。
  • 糖尿病与既往脆性骨折并存时,一般人群全因死亡风险最高。

研究设计与样本

  • 观察性研究纳入哥本哈根城市心脏研究和哥本哈根一般人群研究共117,054人,以及英国生物银行390,374人。
  • 采用单样本孟德尔随机化分析,并将MAGIC中196,743人的空腹血糖和HbA1c汇总数据与哥本哈根研究的脆性骨折数据进行两样本孟德尔随机化分析。
  • 脆性骨折定义为髋部、脊柱和臂部(肱骨/腕部)骨折,数据来自国家健康登记系统。

主要发现

  • 空腹及非空腹血糖和HbA1c浓度升高与任何脆性骨折风险增加相关(p<0.001)。
  • 与无糖尿病者相比,1型糖尿病患者脆性骨折HR 1.50(95%CI 1.19,1.88),2型糖尿病患者HR 1.22(95%CI 1.13,1.32)。
  • 单样本孟德尔随机化显示高非空腹血糖与臂部骨折风险增加因果相关(RR 1.41,95%CI 1.11,1.79,p=0.004)。
  • 两样本孟德尔随机化中,空腹血糖与臂部骨折OR 1.50(95%CI 1.03,2.18,p=0.03),HbA1c与臂部骨折OR 2.79(95%CI 1.12,6.93,p=0.03)。
  • 两样本孟德尔随机化对任何脆性骨折的对应估计分别为:空腹血糖OR 1.18(95%CI 1.00,1.41,p=0.06)、HbA1c OR 1.36(95%CI 0.89,2.09,p=0.15)和OR 2.47(95%CI 0.95,6.43,p=0.06)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Fragility fractures may be a complication of diabetes, partly caused by chronic hyperglycaemia. We hypothesised that: (1) individuals with hyperglycaemia and diabetes have increased risk of fragility fracture; (2) hyperglycaemia is causally associated with increased risk of fragility fracture; and (3) diabetes and fragility fracture jointly associate with the highest risk of all-cause mortality. METHODS: In total, 117,054 individuals from the Copenhagen City Heart Study and the Copenhagen General Population Study (the Copenhagen studies) and 390,374 individuals from UK Biobank were included for observational and one-sample Mendelian randomisation (MR) analyses. Fragility fractures were defined as fractures at the hip, spine and arm (humerus/wrist), collected from national health registries. Summary data for fasting glucose and HbA1c concentrations from 196,743 individuals in the Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) were combined with data on fragility fractures from the Copenhagen studies in two-sample MR analyses. RESULTS: Higher fasting and non-fasting glucose and HbA1c concentrations were associated with higher risk of any fragility fracture (p<0.001). Individuals with vs without diabetes had HRs for fragility fracture of 1.50 (95% CI 1.19, 1.88) in type 1 diabetes and 1.22 (1.13, 1.32) in type 2 diabetes. One-sample MR supported a causal association between high non-fasting glucose concentrations and increased risk of arm fracture in the Copenhagen studies and UK Biobank combined (RR 1.41 [1.11, 1.79], p=0.004), with similar results for fasting glucose and HbA1c in two-sample MR analyses (ORs 1.50 [1.03, 2.18], p=0.03; and 2.79 [1.12, 6.93], p=0.03, respectively). The corresponding MR estimates for any fragility fracture were 1.18 (1.00, 1.41), p=0.06; 1.36 (0.89, 2.09), p=0.15; and 2.47 (0.95, 6.43), p=0.06, respectively. At age 80 years, cumulative death was 27% in individuals with fragility fracture only, 54% in those with diabetes only, 67% in individuals with both conditions and 17% in those with neither. CONCLUSIONS/INTERPRETATION: Hyperglycaemia and diabetes are risk factors for fragility fracture and one- and two-sample MR analyses supported a causal effect of hyperglycaemia on arm fractures. Diabetes and previous fragility fracture jointly conferred the highest risk of death in the general population.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Emanuelsson F, Afzal S, Jørgensen NR, et al. Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies. Diabetologia. 2023. PMID: 38095658. doi:10.1007/s00125-023-06054-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。